Related Experiment Video
Updated: Aug 8, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
[Short QT Syndromes]
1Medizinische Klinik und Poliklinik C (Kardiologie und Angiologie), Universitätsklinikum Münster (UKM), Münster. Schulze-Bahr@ukmuenster.de
Abstract:
The inherited short QT syndrome (SQTS) is a novel, genetically determined arrhythmia that resembles the pathophysiological counterpart of congenital long QT syndrome (LQTS). Gain-of-function ion channel mutations in cardiac potassium channel genes are the currently known cause of SQTS and obvious genetic heterogeneity is evident from the few reported families. At present, three subforms are known, and probably, specific T-wave patterns make each subform recognizable. So far, only a few cases have been genetically unraveled. Treatment includes ICD implantation as the first-line option due to a high occurrence rate of ventricular fibrillation and repolarization-prolonging medications such as quinidine are under investigation. Whenever atrial and/or ventricular fibrillation occur in an idiopathic setting, SQTS has to be considered a potential cause.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

